Skip to main content

Table 1 Baseline Characteristics of included Patients (total 44 patients)

From: The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial

 

Control Group

(n = 14)

Test Group 1

(n = 15)

Test Group 2

(n = 15)

p-value

Age(yr)

<30

0 (0.0%)

0 (0.0%)

3 (20.0%)

0.143

30≤ <40

1 (7.1%)

2 (13.3%)

1 (6.7%)

 

40≤ <50

5 (35.7%)

9 (60.0%)

7 (46.7%)

 

50≤

8 (57.1%)

4 (26.7%)

4 (26.7%)

 

mean(range,yr)

52.2(39-68)

47.4(37-57)

442.(26-76)

0.112

Pathology

Fibroadenoma

4 (28.6%)

6 (40.0%)

7 (46.7%)

0.384

Phyllodes tumor

0 (0.0%)

1 (6.7%)

1 (6.7%)

 

Atypical ductal hyperplasia

4 (28.6%)

0 (0.0%)

0 (0.0%)

 

Intraductal papilloma

2 (14.3%)

3 (20.0%)

4 (26.7%)

 

Malignancy

1 (7.1%)

2 (13.3%)

2 (13.2%)

 

Others

3 (21.4%)

3 (20.0%)

1 (6.7%)

 

the longest length on pre OP-US (cm)

<1

8 (57.1%)

5 (33.3%)

7 (46.7%)

0.500

1≤ <2

5 (35.7%)

9 (60.0%)

6 (40.0%)

 

2≤

1 (7.1%)

1 (6.7%)

2 (13.3%)

 

mean(range,cm)

1.0(0.4-2.7)

1.2(0.6-2.8)

1.3(0.6-2.7)

0.379

the longest length of excised specimen (cm)

<1

0 (0.0%)

1 (6.7%)

1 (6.7%)

0.253

1≤ <2

1 (7.1%)

3 (20.0%)

2 (13.3%)

 

2≤ <3

6 (42.9%)

7 (46.7%)

7 (46.7%)

 

3≤ <4

5 (35.7%)

1 (6.7%)

4 (26.7%)

 

4≤

2 (14.3%)

3 (20.0%)

1 (6.7%)

 

mean(range,cm)

3.0(1.5-8.0)

2.4(0.8-4.0)

2.5(0.6-6.2)

0.247

  1. yr. year, OP operation, US ultra sound